Shockwave Medical is a medical device company that focuses on developing and commercializing innovative products to treat complex calcified cardiovascular diseases. Their flagship product, the Shockwave Intravascular Lithotripsy (IVL) System, utilizes sonic pressure waves to safely and effectively treat calcified plaque in arteries. By using this advanced technology, Shockwave Medical aims to improve patient outcomes and revolutionize the treatment of cardiovascular diseases.

The stock of Shockwave Medical has shown promising signs in its technical analysis. It has formed a solid base, indicating a period of consolidation and stability. This base formation suggests that the stock has found support at a certain price level, which can serve as a launching pad for further upward movement. 

Furthermore, if the stock price of Shockwave Medical surpasses the 320 level, it would indicate a bullish bias and increase the likelihood of reaching the 420 level. This upward bias suggests that there is potential for significant price appreciation in the future.